A new cream called PXS-6302 is showing remarkable promise in reducing stubborn scars. Developed by Professor Fiona Wood’s team in Australia, the treatment works by blocking an enzyme called lysyl oxidase (LOX), which is responsible for making scar collagen dense and stiff. By targeting this enzyme, the cream helps scar tissue remodel into a more natural, flexible state.

In a 3-month clinical trial, scars treated with the cream showed around 66% lower LOX activity, visibly softer tissue, and reduced collagen buildup — all without serious side effects. Researchers believe this innovation could transform scar treatment, offering hope to millions living with keloids, burns, and surgical marks. Could this be the future of scar-free healing?

Core discovery & research
#MedicalBreakthrough #Dermatology #LifeSciences #FutureOfMedicine #ClinicalResearch

Treatment focus
#ScarTreatment #ScarReduction #SkinHealing #RegenerativeMedicine #InnovativeMedicine

Impact & hope
#HopeForPatients #BurnCare #KeloidTreatment #SkinHealth #NextGenSkincare